Procter & Gamble Q3 net profit jumps 16 percent to Rs 59 crore

By

Maverick Martins

Published
May 16, 2023

Procter & Gamble (P&G) Health witnessed a 16 percent rise in net profit to Rs 59 crore ($7.2 million) for the third quarter ended March 31, as against Rs 51 crore in the corresponding period last year.

The company’s total sales for the quarter rose by 21 percent to Rs 316 crore, as against Rs 262 crore in the year-ago period.

The company’s sales for the nine-month period ending March 31, 2023, stood at Rs 913 crore while its net profit for the period was Rs 200 crore.

Commenting on the results, Milind Thatte, managing director at P&G Health India in a statement said, “We continue to register a consistent growth in this quarter despite a challenging macro-economic environment. This has been made possible through our integrated growth strategies of expanded reach and improved productivity, while we continue to create awareness among our patients and consumers alike.”

“The cornerstone of our approach continues to be our robust product line, which helps meet the rising demand for daily supplements, thereby helping us deliver the 6th consecutive quarter of strong growth,” he added.

Procter & Gamble Health is one of India’s fastest growing FMCG companies with a strong presence in the health and personal care sector.